Pricey weight loss drugs like Wegovy and Mounjaro have exploded in popularity, creating opportunities for counterfeit drug manufacturers and challenges for regulators and enforcers. In the final episode of Season 5, Keturah Taylor talks with Cozen O’Connor colleagues Danielle Sapega and Rick Van Buren about the state of federal and state regulation and enforcement and they outline a road map to help legitimate market participants avoid pitfalls.
LISTEN HERE